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Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers in the world which is highly
chemoresistant to currently available chemotherapeutic agents. Thus, novel therapeutic targets are needed to be
sought for the successful treatment of HCC. Peptaibols, a family of peptides synthesized non-ribosomally by the
Trichoderma species and other fungi, exhibit antibiotic activities against bacteria and fungi. Few studies recently
showed that peptaibols exerted cytotoxicity toward human lung epithelial and breast carcinoma cells. However,
the mechanism involved in peptaibol-induced cell death remains poorly understood.
Results: Here, we showed that Trichokonin VI (TK VI), a peptaibol from Trichoderma pseudokoningii SMF2, induced
growth inhibition of HCC cells in a dose-dependent manner. It did not obviously impair the viability of normal liver
cells at lower concentration. Moreover, the suppression of cell viability resulted from the programmed cell death
(PCD) with characteristics of apoptosis and autophagy. An influx of Ca
2+ triggered the activation of μ-calpain and
proceeded to the translocation of Bax to mitochondria and subsequent promotion of apoptosis. On the other
hand, typically morphological characteristics consistent with autophagy were also observed by punctate
distribution of MDC staining and the induction of LC3-II, including extensive autophagic vacuolization and
enclosure of cell organelles by these autophagosomes. More significantly, specific depletion of Bak expression by
small RNA interfering (siRNA) could partly attenuate TK VI-induced autophagy. However, siRNA against Bax led to
increased autophagy.
Conclusion: Taken together, these findings showed for the first time that peptaibols were novel regulators
involved in both apoptosis and autophagy, suggesting that the class of peptaibols might serve as potential
suppressors of tumor cells.
Background
Hepatocellular carcinoma is the fifth most common
solid tumor worldwide and the fourth leading cause of
cancer-related death. Although the majority of tumors
initially respond to chemotherapy, hepatocellular carci-
noma is well known for its expression of the multidrug
resistance gene and its poor response to currently avail-
able chemotherapeutic agents [1,2]. Therefore, it is
necessary to intensify our efforts to understand better
and develop novel treatment for hepatocellular carci-
noma. Promoting PCD is a strategy for cancer drug dis-
covery. Thus there is still a significant need to explore
novel antitumor agents targeted for cancer therapy and
to identify mechanism-based regulators potentially use-
ful in future clinical applications [3,4]. Peptaibols, a
large family of antibiotic peptides, have been identified
mainly from fungi of the genera Trichoderma and Glio-
cladium [5]. At present, the sequences of 309 peptaibols
are known, 184 sequences of which are from the genus
Trichoderma http://www.cryst.bbk.ac.uk/peptaibol/home.
shtml[6,7]. The most common researches on peptaibols
emphasize the biosynthetic pathway, conformational
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biological activities. However, there are few reports
about the effects of peptaibols on human cells or cancer
cells [8,9]. Peltola [10] reported that the peptaibols from
Trichoderma harzianum suppressed the growth of A549
cells and dissipated the mitochondrial membrane poten-
tial (ΔΨm). However, the precise mechanism and the
basic components in cellular death pathway involved in
peptaibol are currently unknown.
Under physiological and pathological settings, PCD
can be classified into several morphological and bio-
chemical subtypes. Among them, the most prominent
types are type-1 cell death (apoptosis) and type-2 cell
death (autophagic cell death, ACD). Recent reviews have
described the relationship of autophagy and apoptosis
signaling during cancer therapy. While the molecular
mechanisms leading to apoptosis have been dissected to
some extent during the past 15 years, ACD is not well
characterized at the molecular level yet [11]. Autophagy
has recently gained much attention for its especial roles
in cell survival and cell death, particularly in the patho-
genesis as well as the treatment of cancer. Not surpris-
ingly, there is an intricate relationship between
autophagy and apoptosis. Early studies showed that
autophagy took over when apoptosis was blocked in
cancer cells. A more recent report demonstrated that
autophagy and apoptosis might interact or occur inde-
pendently of each other [12,13]. Therefore, the interplay
between autophagy and apoptosis is unclear. A debate
issue is whether crosstalk between these two pathways
exists and how cell death declines to one or the other
subroutine.
Previous studies have indicated that the elevation of
[Ca
2+]i was a sufficient signal to induce apoptosis in sev-
eral model systems [14]. It is important to elucidate
whether cells undergo apoptosis, autophagy, or both, in
the response to calcium elevation [15]. Calpain is an
intracellular cysteine protease that modulates Ca
2
+-dependent apoptosis through a variety of mechanisms.
The best-characterized calpains are two ubiquitously
expressed isozymes, μ-calpain and m-calpain, sharing
homology in their protease domains. To become active,
calpains require an elevation in [Ca
2+]i, and the autopro-
teolytic cleavage to further enhance their activity. Recent
studies have indicated that calpains may play a central
role in the execution of calcium-triggered cell death
upstream of caspases. Moreover, calpain has been impli-
cated in the translocation of Bax to the mitochondria.
In addition, calpain has been reported to cleave Bid, a
BH3-only Bcl-2 family protein, resulting in the cyto-
chrome c (Cyto-c) release from mitochondria [16-18]. It
has also been suggested that Bcl-2 family members
(Bax/Bak and Bcl-2/Bcl-xL) could promote or inhibit
the apoptosis and autophagy presumably through an
alternate mechanism [15,19]. It is not well known that a
cell decide whether to undergo apoptosis, autophagy, or
both, in the response to calcium elevation and the role
of Bcl-2 family members in regulating calcium signals
and proceeding of autophagy.
Trichokonins (TKs) secreted by T. koningii are peptai-
bols which are composed of 20 amino acids. Three TKs,
TK VI, TK VII and TK VIII, have been isolated from
Trichoderma spp. SMF2, and their sequences have been
identified [20-22]. Strain SMF2 was described as T.
koningii in our previous reports [22]. However, through
analyses of its colony, conidiophore morphology, 18S
rDNA and ITS sequences (Gene Bank accession number
FJ605099), strain SMF2 was recently identified as T.
pseudokoningii (see Additional file 1). Like other peptai-
bols, TKs have been shown to have antibacterial and
antifungal properties. In this paper, we identified TK VI
as a novel cell death regulator by studying its cytotoxic
effects on cancer cells and HCC cells (HepG2 cells).
Our results first provided molecular evidence to demon-
strate a novel finding that TK VI induced two types of
cell death, including calcium-calpain-Bax-mediated
apoptosis and calcium-Bak-mediated autophagy in
HepG2 cells.
Results
TK VI predisposed cancer cells to apoptosis accompanied
by morphological changes compatible with autophagy
To assess whether TK VI induced cell death, MTT assay
was used to measure the relative survival of cells. When
BGC-823, A549 and HepG2 cells were incubated with
increasing concentrations of TK VI, TK VI and etopo-
side caused a dose-dependent inhibition of cell prolifera-
tion, whereas the inhibitory effect of TK VI was
approximately two-fold higher than that of etoposide
with concentrations ranging from 30 to 40 μM( F i g u r e .
1A). Further cytometric analysis using FITC-labeled
annexin V showed that all three cell lines treated with
20 μM TK VI for 8 h exhibited significant increases in
apoptosis (Figure 1B).
Whether TK VI had different effects on hepatocellular
carcinoma and normal liver cells were further deter-
mined. The human hepatocellular carcinoma cell lines
HepG2, Hep3B and human liver cell line Chang were
treated with increasing concentration of TK VI. As
shown in figure 1C, TK VI caused a dose-dependent
inhibition on cell proliferation of three cell lines with
concentrations ranging from 10 to 40 μM. However, at
lower concentration, TK VI did not obviously impair
the viability of normal liver cells. Moreover, a 3’ end
labeling of DNA assay in HepG2 cells using fluorescence
microscopy showed positive results (Figure 1D). The
percentage of HepG2 cells showing apoptosis (positive
TUNEL reaction) was further determined by FACS
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Page 2 of 15Figure 1 Assessment of cell death and apoptosis induced by TK VI. (A) Cells were treated with TK VI or etoposide, ranging from 10 to 40
μM and incubated in 10% FBS-DMEM complete medium at 37°C for 24 h. Viable cells were measured by MTT assay. Results were expressed as
means ± SD of triplicate experiments (each performed in duplicate). Black solid line: HepG2 cells; Red short dash line: BGC cells; Blue dot line:
A549 cells. Asterisks indicated values significantly different from cells treated with etoposide. *P < 0.05; **P < 0.01. (B) Cells were treated with 20
μM TK VI for 8 h and then apoptosis were analyzed on a flow cytometer using annexin V/PI staining methods. Data were representative of three
independent experiments. Numbers in the respective quadrants indicated the percentage of the cells present in this area. (C) The HepG2, Hep3B
and Chang liver cells were incubated with TK VI and detected as described in A. Results were expressed as means ± SD of triplicate experiments
(each performed in duplicate). ## indicated values significantly different from Chang liver cells (
##P < 0.05). (D) HepG2 cells were treated with 20
μM TK VI or etoposide for 24 h. Then DNA fragmentation in the cells was viewed using fluorescence microscopy. (E) The quantitative analysis of
apoptosis in cells was analyzed by FACS using TUNEL staining. Results were expressed as means ± SD of triplicate experiments (each performed
in duplicate). Asterisks indicated values significantly different from controls and Z-VAD-treated cells. **P < 0.01. (F) DNA was extracted from
HepG2 cells cultured for 36 h with 20 μM TK VI and DNA ladder was detected by agarose gel electrophoresis.
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etoposide for 24 h, about 90% and 80% of HepG2 cells
showed apoptosis, respectively. However, the apoptotic
populations in cells treated with TK VI and Z-VAD-fmk
were dramatically decreased in contrast to cells treated
TK VI alone. In addition, 3-MA had no effect on TK
VI-induced apoptosis. Nevertheless, compared with eto-
poside-treated cells, DNA laddering was less pro-
nounced in TK VI- treated cells (Figure 1F). These
results indicated that TK VI-treated cells displayed a sig-
nificant apoptotic character in a caspase-dependent
manner.
It has been reported MDC as a specific marker for
autolysosomes [23]. Therefore, we studied the incor-
poration of MDC in the cells where autophagy was sti-
mulated by TK VI using fluorescence microscopy. As
shown in Figure 2A, cells treated with TK VI for 24 h
showed an increase in the number of vesicles as well as
in their size, indicating the formation of the MDC-
labeled vacuoles. MDC was concentrated in the spheri-
cal structures distributed in the cytoplasm and also loca-
lized in the perinuclear region. LC3 exists as two forms,
such as an 18 kDa cytosolic protein (LC3-I) and a pro-
cessed 16 kDa form (LC3-II) in the cells engaged in
autophagy. Studies have also revealed that the LC3-II
form is mainly localized in autophagosome membranes
[24]. In order to test the involvement of LC3 in TK VI-
induced autophagy, we initially determined the effect of
TK VI treatment on the localization of LC3 by immuno-
cytochemical analysis and the results are shown in Fig-
ure 2B. The control HepG2 cells exhibited diffused
distribution of LC3-associated green fluorescence. On
the other hand, HepG2 cells treated with TK VI for 16
h displayed a punctate pattern of LC3-II immunostained
with increased fluorescence, which characterized its
redistribution to autophagosomes. By contrast, in the
presence of 3-MA, an autophagy-specific inhibitor,
autophagy was prevented effectively. Moreover, the pre-
treatment of cells with Z-VAD-fmk produced a slightly
enhanced punctate pattern of LC3-II fluorescence, indi-
cating the blockage of apoptosis could mildly promote
TK VI-mediated autophagy (Figure 2B). The percentage
of autophagic cells was further determined by FACS
using staining with an acridine orange fluorescence dye
and the results were similar to Figure 2B (Figure 2C).
Next, we tested whether TK VI treatment caused pro-
ceeding of full-length LC3-I (18 kDa) to LC3-II (16
kDa) by performing immunoblotting using lysates from
HepG2 cells treated with TK VI alone or combined with
z-VAD-fmk and 3-MA (Figure 2D). The results were
consistent with Figure 2B. These results collectively sug-
gested that treatment with TK VI specifically and effi-
ciently induced autophagy in HepG2 cells. More
importantly, using MTT assay to monitor the effects of
3-MA on cell viability (Figure 2E), we observed that
after 24 h of 20 μM TK VI exposure, the percentage of
viable cells increased, but there was relatively minor
effect. On the other hand, the proportions of viable
HepG2 cells after treatment with TK VI significantly
increased from 66% to 86% in the presence of Z-VAD-
fmk. Furthermore, co-treatment with Z-VAD-fmk and
3-MA had additive effects on cell viability. Taken
together, TK VI induced two types of cell death in
HepG2 cells, including both apoptosis and autophagy
and the TK VI-induced apoptosis mainly attributed to
cell death.
TK VI increased [Ca
2+]c in a time and dose-dependent
manner
The elevation in [Ca
2+]c due to the influx of Ca
2+ across
t h ec e l lm e m b r a n eo rt h er e l e a s eo fi n t r a c e l l u l a rC a
2+
stores, may mediate apoptosis [25]. Cells were treated
with A23187, a classical calcium carrier, as a positive
control (Figure 3A). To investigate whether TK VI and
Alamethicin led to the [Ca
2+]c increase, [Ca
2+]c measure-
ments were performed using laser scanning microscopy.
[Ca
2+]c was measured confocally on the single-cell level
with fluo-3. Typical fluo-3 fluorescence images
(recorded at 780-nm excitation) were presented at indi-
cated times (Figure 3B and 3C). When HepG2 cells
were exposed to 10 μM Alamethicin or TK VI in med-
ium containing 2 mM CaCl2, about one-third the cells
in the image displayed high fluorescence intensity (Fig-
ure 3B, right panel and Figure 3C, middle panel). While
HepG2 cells were exposed to 10 μMT KV Io rA l a -
methicin in the medium without the addition of Ca
2+,
the Fluo-3 intensity did not appreciably alter in the cells
(Figure 3B, left panel and Figure 3C, left panel). The
fluo-3 fluorescence traces from the representative cells
are presented. The results indicated that TK VI pro-
moted an increase in [Ca
2+]c in a time-dependent man-
ner, which originated from an influx of extracellular Ca
2
+. When the concentration of TK VI was increased from
10 to 20 μM, the intensity of fluo-3 fluorescence signifi-
cantly increased with the increase of TK VI concentra-
tion (Figure 3C, right panel), indicating that TK VI
treatment also increased [Ca
2+]c in a dose-dependent
manner.
Calpain was a key factor in calcium-originated pathway in
TK VI-treated cells
The activation of calpain is demonstrated by the autop-
roteolytic cleavage, which is a specific marker for calpain
activation [26]. To investigate whether calcium-depen-
dent proteases, calpains, were activated during the treat-
ment of HepG2 cells with TK VI, the cleavage of
calpain into its active form was first analyzed by immu-
noblot analysis. As shown in Figure 4A, the cells treated
with TK VI and Alamethicin contained a cleaved form
of μ-calpain. Calpains can be upstream mediators of
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Page 4 of 15Figure 2 Assessment of cell death and autophagy induced by TK VI. (A) Monodansycadaverine (MDC)-labeled vesicles (indicated by arrows)
were induced by TK VI. HepG2, BGC and A549 cells were incubated in DMEM medium (control cells) or treated with 20 μM TK VI and etoposide
at 37°C for 24 h. Cells were immediately analyzed by fluorescence. (B) Iimmunocytochemistry for LC3 localization in HepG2 cells treated for 16 h
with TK VI alone and combined with Z-VAD-fmk or 3 MA. a: control; b to d: cell treated with TK VI+3-MA, TKVI, and TK VI +Z-VAD-fmk. (C) Cells
were treated the same as decribed in (B) and analyzed by acridine orange staining using flow cytometry for autophagy. Results were expressed
as means ± SD of triplicate experiments (each performed in duplicate). Asterisks indicated values significantly different from controls and 3-MA-
treated cells. **P < 0.01. (D) Cells were treated the same as decribed in (B). Cell lysates were analyzed using Western blotting with anti-LC3 and
-actin antibodies. b-actin was used as an internal control to normalize the amount of proteins applied in each lane. (E) HepG2 cells were
pretreated with 3-MA or Z-VAD-fmk for 1 h, followed by treatment with 20 μM TK VI for 24 h to determine cell viability using MTT assay.
Asterisks indicate values significantly different from cells only treated with TK VI. *P < 0.05.
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through the activation of some Bcl-2 family members.
Bax is critical for the breakdown of the mitochondrial
potential by translocating to the mitochondria after a
cell receives death stimuli [27]. Therefore, Bak and Bax
activation in HepG2 cells treated with TK VI was exam-
ined by immunohistochemical method. To confirm
whether Bak was activated in response to TK VI,
HepG2 cells were incubated with a unique antibody that
was only accessible to activated Bak. It was observed
that treated cells displayed a bright, punctuate staining
pattern of Bak antibody after 8 h treatment (Figure 4B),
while this pattern was not seen in control cells. In the
cells pre-treated with BAPTA, Bak remained inactive
after TK VI treatment. On the contrary, inhibition of
calpain by SJA6017, calpain inhibitors, had no effects on
the activation of Bak, indicating that activation of Bak
was only enhanced in the presence of [Ca
2+]c,b u tn o t
calpain. Furthermore, consistent with the previous
reports [26,27], our results showed that Bax translocated
to the mitochondria and redistributed in the
mitochondria after TK VI treatment. However, if the
cells were pre-treated with BAPTA or SJA6017, Bax was
still located in the cytosol of the cells and remained
inactive after TK VI treatment (Figure 4C). Under the
same conditions, the results of immunoblot analysis
were similar to that of the immunohistochemical detec-
tion (Figure 4D). These results indicated that activated
calpain induced Bax activation and translocation to
mitochondria after TK VI treatment.
Bak played as a major factor in calcium-originated
autophagic cell death induced by TK VI
Previous studies showed that Bak was a typical cell
death determinant, and Bcl-2 famlily proteins were
essential links between apoptosis and autophagy [28]. A
Bak and Bax-interfered cell line (Bak siRNA cells and
Bax siRNA cells) was constructed from HepG2/Bak
+/+
and HepG2/Bax
+/+ cells, and reduction of Bak and Bax
expression in cells were detected by immunoblot analy-
sis, respectively (Figure 5A and 5B). In this study, we
observed that control cells underwent visible autophagy
after treatment with TK VI for 16 h, but Autophagy was
Figure 3 Assessment of TK VI-induced [Ca
2+]c increases using confocal fluo-3 fluorescence imaging. (A)A23187 was a positive control for
agitation of [Ca
2+]c. (B) and (C), HepG2 cells were loaded with Fluo-3 acetoxymethyl ester and treated with 10 and 20 μM TK VI or Alamethicin
(ALam, a classical representative of peptaibols) diluted in PBS alone or containing 2 mM CaCl2. Then cells were examined from 0 to 900 sec for
Fluo-3 fluorescence intensity. Original trace of fluorescence intensity as a measure of [Ca
2+]c recorded from the cells was marked in the confocal
images. TK VI-induced [Ca
2+]c increase was assessed by using confocal two-photon fluo-3 fluorescence imaging. (B: right panel and C: middle
and right panel). Three cells responded to TK VI stimulation with an increase in fluo-3 fluorescence intensity were used as a measure of [Ca
2+]c
(indicated with arrows). The graph was labeled with arabic numbers that referred to the images. The images of cells treated with TK VI and
Alamethicin (10 μM) diluted in PBS alone were shown in left panels in B and C.
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Page 6 of 15Figure 4 The status of calpain in TK VI-treated cells. (A) Protein samples derived from HepG2 cells treated with 20 μMT KV If o r8hw e r e
analyzed by immunoblotting. The 80-kDa pro-form of μ-calpain appeared as an abundant band, and the cleaved 78-kDa form of the enzyme
was visible in some samples just below the pro-form. (B) HepG2 cells were pretreated with BAPTA and SJA6017, followed by 20 μM TK VI for 8 h.
Then activation of Bak was detected with activated N-terminal anti-Bak antibody and mitochondria were visualized with red fluorescent protein
(Mito-red) by imunofluorescence microscopy. (C) The cells were incubated with TK VI as described in (B). Mitochondria were visualized with red
fluorescent protein (Mito-red). The redistribution of Bax was marked with FITC-conjugated anti-mouse and assessed by confocal
immunofluorescence. (D) The cells were incubated with TK VI as described in (B). Equal amounts of mitochondrial proteins was isolated from
HepG2 cells and then subjected to immunoblot analysis. Cox IV was used as a marker for mitochondrial fraction.
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control cells. Unexpectedly, Bak siRNA cells exerted a
remarkable decrease in autophagy (Figure 5C). Next, we
tested whether Bak siRNA and Bax siRNA cells treated
with TK VI caused proceeding of full-length LC3-I to
LC3-II, a hallmark of autophagy. As shown in Figure
5D, the levels of LC3-II proteins dramatically increased
after treatment with TK VI in Bax siRNA cells. In the
meantime, cells pretreated with BAPTA and Bak siRNA
cells did not show corresponding increase in LC3-II
proteins. Transmission electron microscopy assay con-
firmed control cells displayed normal cell morphology
(Figure 5E, a). Approximately 30-35% of the TK VI-trea-
ted cells developed vacuoles after 24 h treatment, some
of which accumulated to form larger vacuoles (Figure
5E, b). At higher magnifications, most vacuoles con-
tained electron dense material and degraded organelles.
Morphologically, the vacuoles primarily originated from
mitochondria. Most cells were strongly vacuolated, and
the size of the vacuoles increased to 2-3 μm. Blockage
of Bak attenuated part of TK VI-induced vacuolization
effect (Figure 5E, c). In contrast, Bax-interfered cells dis-
played increasedly vacuolated morphology (Figure 5E,
d). Taken together, the results indicated that [Ca
2+]c was
an indispensable factor in the autophagic cell death and
Bak played a major role in autophagy induced by TK
VI. Moreover, the inhibition of Bax could obviously
enhance autophagic sensitization in cells.
Translocation of Bax was essential for TK VI-
mediatedapoptosis
The effect of calcium and calpain on apoptosis was first
analyzed in HepG2 cells. When cells were exposed in
the presence of BAPTA-AM, an effective inhibition in
TK VI mediated activation of calpain was shown and
TK VI-stimulated PCD was reduced (Figure 4A and
6A). In addition, the calpain inhibitor SJA6017 partially
attenuated the TK VI-stimulated apoptosis. These
results showed that Ca
2+ influx was a prerequisite in TK
VI-mediated apoptosis, and subsequent activation of cal-
pain was necessary for the process. In normal cells, the
Bax protein exists as an inactive form in the cytosol, but
it can be induced to change conformation and translo-
cate to the mitochondria in the response to certain
apoptotic stimuli [29]. After 24 h treatment with TK VI,
most control siRNA cells underwent apoptosis, whereas
little apoptosis was observed in Bax siRNA cells (Figure
6B). Even after 48-h treatment, only a few Bax siRNA
cells underwent cell death (data not shown). Along with
results shown in Figure 4C, the data suggested that Bax
was required for TK VI-induced apoptosis in HepG2
cells.
In the course of mitochondrial apoptosis, the loss of
ΔΨm and the release of cytochrome c from the mito-
chondrial intermembrane space into the cytosol are the
major events [30]. Flow cytometry analysis showed that
TK VI-treated cells displayed a significantly higher per-
centage of cells with damaged mitochondria after 16 h
treatment. These results showed TK VI promoted mito-
chondrial transmembrane potential dissipation. Interest-
ingly, blockage of Bax drastically reduced dissipation of
ΔΨm(Figure 6C), and subsequently almost completely
inhibited the release of cytochrome c and Smac (Figure
6D) in TK VI-treated cells. Moreover, after 4-h TK VI
treatment, the cleaved forms of caspase-3 and PARP
appeared in control siRNA cells. In contrast, cleavage of
procaspase-3 and PARP was absent in Bax siRNA cells
(Figure 6E). These results showed that the mitochon-
drial pathway, as well as activation of procaspase-3 and
PARP, was induced by TK VI treatment in a Bax-depen-
dent manner.
Bcl-xL down-regulation was required for TK VI-
inducedapoptosis
Bcl-xL inhibits cell death by blocking the formation of
the cytochrome c-releasing pores. Previous studies
showed that Bcl-xL is down-regulated during apoptosis
induced by chemotherapy reagents [31]. After treatment
with TK VI, the level of Bcl-xL decreased in HepG2
cells (Figure 7A). Compared with the control/neo cells,
approximately 2-fold higher level of Bcl-xL was
expressed in the Bcl-xL-overexpression cells (Figure 7B).
Apoptosis was induced in 60% of Control/neo cells after
16 h of TK VI treatment, but a little apoptotic cell
death was observed in the Bcl-xl-overexpression cells
treated with TK VI for 24 h (Figure 7C). In addition,
dissipation of ΔΨm was retarded (Figure 7D), following
as i g n i f i c a n td e l a yi nt h er e l e a s eo fc y t o c h r o m ec and
Smac/DIABLO by the reason of overexpression of Bcl-
xL (Figure 7E). As revealed in Figure 7F, the change in
percentage of autophagic cells was almost not detected.
These results confirmed that TK VI-induced apoptosis
was sustained by mitochondrial release of apoptotic
molecules, which triggered primarily by the regulation
of Bax and Bcl-xL in HepG2 cells (Figure 6 and Figure
7).
Discussion
Peptaibols are a family of antibiotic peptides isolated
from soil fungi that exhibit anti-bacterial and anti-fungal
properties [32]. Few studies show they have the capacity
to induce cell death in human cancer cells [10,33,34]. In
this report, we first used HepG2, BGC-823 and A549
cell lines as models for MTT assay and found that TK
VI inhibited the growth of the three cell lines in vitro.
Most significantly, HepG2 cells were more sensitive to
TK VI than normal liver cells with lower concentration
of TK VI (from 10 to 20 μM) (Figure 1), indicating that
peptaibol might be a potentially novel anticancer agent.
Furthermore, TK VI induced a form of apoptotic and
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Page 8 of 15autophagic cell death in HepG2 cells, which was charac-
terized by extensive vacuolization, surface exposure of
PS, and loss of mitochondrial membrane. Moreover, the
apoptotic process was caspase-dependent. In addition,
cell death induced by TK VI was mainly characteristic
of apoptosis in HepG2 cells, whereas small interfering
RNAs against Bax led to increased autophagy. Interest-
ingly, the kinetics of Ca
2+ influx correlated well with the
onset of apoptosis and autophagy, suggesting that Ca
2+
might play a direct role in these processes. Calcium
caused a significant activation of Bak and thus promoted
authphagic pathway in TK VI-treated cells.
Changes in intracellular Ca
2+ have been reported to
occur at the beginning of cell death, induced by pore-
forming toxins or peptides from bacteria, animals and
plants. The fact that peptaibols formed ion channels in
Figure 6 The requirement of translocation of Bax in TK VI-induced apoptotic cell death. (A) HepG2 cells were treated with 20 μMT KV I
for 8 h, or pretreated with calpain inhibitor (SJA6017, 100 μM) and chelators of calcium (BAPTA acetoxymethyl ester, 10 mM). Subsequently, cells
were assessed for the exposure of PS with annexin V staining and for viability with PI exclusion by flow cytometry (one representative of three
similar experiments). Numbers in the respective quadrants indicated the percentage of the cells present in this area. (B) and (C) Apoptotic cells
and dissipation of ΔΨm were quantified by FACS analysis. HepG2 cells were transfected with Bax siRNA or control siRNA. HepG2 cells were
treated by 20 μM TK VI for indicated time periods and stained by annexin V and Rhodamine 123. Quantification of the percentage of apoptotic
cells and changes in the mitochondrial membrane potential were detected using Flow Cytometry. Asterisks indicated values significantly
different from Bax siRNA cells. **P < 0.01. (D) Change of Cyto-c and Smac distribution was detected after 8-h TK VI (20 μM) treatment.
Mitochondria were visualized with red fluorescent protein (Mito-red) and Cyto-c or Smac was marked with FITC-conjugated anti-mouse and anti-
rabbit IgG, respectively. (E) The cleavage of procaspase-3 and PARP were detected after 16 h of TK VI treatment. Data represented means and
SD. from three independent experiments.
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Page 9 of 15phospholipid bilayers [7] prompted us to investigate the
effect of TK VI treatment on intracellular Ca
2+ levels.
Our results suggested that TK VI initially induced an
increase in [Ca
2+]c in HepG2 cells, which originated
from an influx of extracellular Ca
2+ (Figure 3). Peptai-
bols are fungal peptides rich in non-coded a-aminoiso-
butyric acids (Aib). The structure, sequence and
amphipathic property of peptaibols play major roles in
its cell-killing mechanism [35,36]. The long sequence
peptaibols with 18-20 amino acid residues, exemplified
by alamethicins [37], were used to explore the channel
formation of these peptides on cells in the “barrel-stave”
model [7,8,37]. Fonteriz reported [38] that alamethicin
seemed to form ionic channels in chromaffin cells,
which were permeable to Ca
2+. Interestingly, in the view
of Qing Hua [39], trichokonin VI was a potent agonist
of L-type Ca
2+ channel. Our results demonstrated that
elevation of [Ca
2+]c attributed to TK VI and it played a
Figure 7 The retardance of apoptosis with overexpression of Bcl-xL. (A) HepG2 cells were treated by 20 μM TK VI and the expression of
Bcl-xL was assessed by Immunoblot assay. (B) HepG2 cells were transfected with a pcDNA3.1 vector containing the coding sequence for Bcl-xL
(Bcl-xL) or with a neomycin-resistant expression vector pcDNA3.1 (Neo, control) by Lipofectin reagent according to the manufacturer’s
instructions. Over-expression of Bcl-xL expression was assessed by Western blot. (C) and (D) Apoptotic cells and Dissipation of ΔΨm were
quantified by FACS analysis. Results were expressed as means ± SD of triplicate experiments (each performed in duplicate). (E) HepG2 cells were
treated by 20 μM TK VI for indicated times. The release of Cyto-c and Smac/DIABLO was assessed in Bcl-xL-overexpression and neo cells by
Immunoblot assay. (F) Cells were treated as (C) and then autophagy was analyzed using flow cytometry with acridine orange dyeing. Asterisks
indicated values significantly different from Bcl-xL-overexpression cells. **P < 0.01.
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autophagy induced by TK VI. More importantly, we
report for the first time that TK VI exhibited its cyto-
toxicity via autophagy through Ca
2+-Bak signaling. We
observed that BAPTA abolished calcium influx and sig-
nificantly reduced TK VI-induced autophagy and apop-
tosis (Figure 5D and Figure 6A). Consistent with our
results, vitamin D, ATP, ionomycin, and photodynamic
therapy were known to induce calcium-mediated autop-
hagy [40]. The involvement of the calpain, a key cal-
cium-dependent protein, in apoptosis was suggested by
previous studies involving different cellular systems [26].
Remarkably, the inhibitors of calpain abrogated the acti-
vation of Bax and further protected HepG2 cells against
apoptosis induced by TK VI. It is noteworthy that cal-
pain inhibitors conferred only a partial protection
against apoptosis (Figure 4C and Figure 6A). Consistent
with this observation, other effective molecules, in addi-
tion to calpains, might be involved in this apoptotic
pathway. Although Bak was not an effector of calpain,
but the influx of Ca
2+ contributed to its activation (Fig-
ure 4B). The results suggested calpain was one of the
major factors in TK VI-mediated apoptosis.
The relationship of autophagy and apoptosis is com-
plex and controversial. It varies with cell and stress dis-
tinction. Depending on the cellular context and
stimulus, autophagy may be indispensable for apoptosis
by turning on apoptosis. In other cellular settings,
autophagy may rather antagonize or delay apoptosis,
and inhibition of autophagy may increase the sensitivity
of the cells to apoptotic signals. In some cell systems,
two processes can occur independently [11,12,41]. In
this study, apoptosis and autophagy were independent
pathways in presences of Bax, which was triggered by
TK VI. But apoptosis played a crucial role in the pro-
cess. Plenty of signaling pathways overlaps are found
between autophagy and apoptosis, including various
kinases such as PI3K, PKB/Akt, Bcl-2 family members,
PTEN, c-Myc, Ras and others [15,42]. Apoptosis was
regulated by the Bcl-2 family (Bak, Bax and Bcl-xL)
which conveyed the death message to mitochondria
[26]. A report [10] demonstrated that T. harzianum
peptaibols dissipated the mitochondrial membrane
potential of human lung epithelial carcinoma cells,
which accorded with our results (Figure 6C). In our
study, ultrastructural characteristics might reveal that
mitochondria lost membrane potential via a vacuolated
manner, whereas, in typical apoptosis, the mitochondria
maintained its shape and volume (Figure 5E). This was
consistent with the report [24] that upon autophagic sti-
mulation, depolarized mitochondria could promote
sequestration and turnover of the damaged mitochon-
dria in degradative vacuoles or autophagosomes. Our
results showed that blockage of Bak would abrogate part
of vacuolization effect induced by TK VI (Figure 5E, c).
Cui Q [43] showed that physiological role Bak might be
the suppression of autophagy. In contrast to previous
studies, our results described a different activity of Bak
during autophagy in TK VI-treated cells. The discovery
heralded a new regulator involved in the induction of
autophagy by calcium in response to TK VI. However,
the mechanism of TK VI-induced vacuole formation
still required further study. In HepG2 cells treated with
TK VI, activated calpain induced subsequent transloca-
tion of Bax from cytosol to mitochondria. Then acti-
vated Bax predisposed to the release of cytochrome c
and Smac, as well as clevage of caspase-3 and PARP. On
the other hand, Buytaert and other researcher [44,45]
demonstrated Bax proceeded to cell killing through
apoptosis in its presence or v i aa na u t o p h a g i cp a t h w a y
in its absence, which was similar to our results. Previous
study [46] showed that moderate expression of Bcl-2 or
Bcl-xL delayed apoptosis but did not prevent the rapid
induction of autophagy. Our results exhibited changes
in the ΔΨm were retarded by overexpression of Bcl-xL,
which resulted in a marked delay in the kinetics of
PCD, whereas, the overexpression of Bcl-xL had no sig-
nificant effect on autophagy.
Based on our results, a novel cell death pathway trig-
gered by antibiotic peptaibol TK VI in HepG2 cells was
proposed. TK VI-induced cell death might represent an
intertwined type of autophagy and apoptosis, which was
previously unknown. TK VI initially acted on the cell
membrane, and then resulted in a Ca
2+ influx from
extracellular medium. It both triggered the activation of
Bak, which mainly involved in autophagy, as well as
induced μ-calpain activation. Upon activation of Bax by
calpain, Bax, in turn, translocated to the mitochondria,
where it promoted loss of ΔΨm and the release of cyto-
chrome c and Smac/DIABLO. Finally, caspase-3, and
PARP were activated, leading to apoptosis. Specific
depletion of Bak expression could partly attenuate TK
VI-induced autophagy. However, blockage of Bax led to
increased autophagy (Figure 8). Antimicrobial peptides
have been receiving increasing attention for their cyto-
toxic activity toward cancer cells that parallels their
antimicrobial activity [47,48]. Our data suggested that
peptaibols might be a new class of candidates for anti-
tumor agents.
Conclusions
In conclusion, this work demonstrated that TK VI
induced growth inhibition of hepatocellular carcinoma
cells (HCC cells) in a dose-dependent manner. However,
at lower concentration, TK VI did not obviously impair
the viability of normal liver cells. In our case, the targets
of TK VI were related to Bax-apoptosis and Bak-autop-
hagy pathway activation. Nevertheless, the validation of
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Page 11 of 15potential use of TK VI required further investigation on
in vivo hepatocellular carcinoma models.
Methods
Reagents
Fluo-3 acetoxymethyl ester (Fluo-3 AM), acridine
o r a n g e ,3 - m e t h y l a d e n i n e( 3 - M A ) ,a n t i - c a s p a s e - 3 ,a n t i -
PARP, anti-calpain, anti-Bax, anti-Smac, anti-Cyc-c and
anti-Bcl-xl monoclonal antibodies were all purchased
from Sigma (Sigma-Aldrich, St Louis, MO). The antibo-
dies for detection of activated Bak were purchased from
Millipore (Charlottesville, VA). DMEM and bovine calf
serum were obtained from Gibco BRL (Grand Island,
NY). benzyloxycarbonyl-Val-Ala-Asp-(OMe) fluoro-
methyl ketone (z-VAD-fmk) was obtained from Onco-
gene Research Products (San Diego, CA). The
secondary antibody (goat anti-rabbit or rabbit anti-
mouse Alexa 488) and 1, 2-Bis (O-aminophenoxy)
ethane-N, N, N-, N-tetraacetic acid (BAPTA) acetoxy-
methyl ester were purchased from Molecular Probes,
Inc. (Eugene, OR).
Purification of Trichokonins T. pseudokoningii
SMF2 was fermented by solid-state fermentation and
TK VI was purified using the methods as previously
described [19,20]. The purified TK VI was dissolved in
PBS.
Cell culture, treatment and establishment of HepG2 cells
stably expressing Bcl-xL
BGC-823, A549 and HepG2 cells were obtained from
the Institute of Biochemistry and Cell Biology (Shanghai,
China). They were grown in DMEM supplemented with
10% fetal calf serum under an atmosphere of 5% CO2.
In this study, HepG2 cells were pretreated with the fol-
lowing compounds: the calpain inhibitor SJA6017 (100
μM), the caspase inhibitor z-VAD-fmk (200 μM), 3-MA
(2 mM), and BAPTA (10 mM).
Figure 8 Scheme of PCD pathway in HCC cells triggered by TK VI.C a
2+ entered through the cell membrane and activated Bak and calpain.
The former ignited autophagy characteristic of cytoplasmic vacuolation and the latter promoted the translocation of Bax, which targeted
mitochondria. On the other hand, Bcl-xL was downregulated almost in concurrence with the translocation of Bax. Bcl-xL overexpression retarded
apoptosis, whereas it had no effect on authoagy. The release of Cyto-c and Smac from mitochondria into the cytosol was triggered by the
preceding events, promoting the acivation of caspase-3 which subsequently led to PARP activation. Specific depletion of Bak expression could
partly attenuate TK VI-induced autophagy. However, blockage of Bax led to increased autophagy.
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(Invitrogen, San Diego, CA) containing the coding
sequence for Bcl-xL (pcDNA3.1/Bcl-xL), or with a con-
trol neomycin-resistant expression vector pcDNA3.1,
using Lipofectin reagent (Invitrogen) according to the
manufacturer’s instructions.
Assessment of apoptosis and autophagy
The MTT tetrazolium assay was performed as previously
described to measure the density of viable cells [17].
Phosphatidylserine (PS) exposure was evaluated by
using the Annexin V-FITC apoptosis detection kit (Bio-
Vision, Mountain View, CA) following the manufac-
turer’s instructions. Annexin V binding was analyzed
equipped with a FITC signal detector FL1 (Ex = 488
nm, Green) and PI staining with a phycoerythrin emis-
sion signal detector FL2 (Ex = 585 nm, Red) using the
FACScan cytometer (Becton Dickinson, San Jose, CA).
Percentage of apoptotic cells of the total (10
6 cells) was
calculated using FlowJo 4.5.2 software.
DNA fragmentation assay was performed for the
detection of DNA strand breaks. The detection was car-
ried out according to the instructions for 3’ end labeling
of DNA in situ (Oncogene Research Products, San
Diego, CA). Percentage of apoptotic cells of the total
(10
6 cells) was calculated using FACScan cytometer.
Additionally, cells were analyzed using NIKON ECLIPSE
TE2000-E fluorescence microscope.
For the determination of DNA fragmentation in oligo-
nucleosomal fragments (DNA laddering), total cellular
DNA was extracted from 5 × 10
6 cells using the Easy-
DNA kit (Invitrogen) following the instructions provided
by the manufacturer. The obtained DNA was analyzed
by electrophoresis on a 1.5% agarose gel.
MitoCapture™ (Biocarta, Hamburg, Germany) was
used to evaluate changes in mitochondrial membrane
potential (ΔΨm). Cell suspensions (5 × 10
5)w e r ei n c u -
bated at 37°C for 15 min in 1 ml PBS containing 1 mM
rhodamine 123, and subsequently analyzed with a
FACSCalibur flow cytometer.
The analysis of autophagy was undergone by MDC as
described previously [21]. The percentage of autophagic
cell death was analyzed using flow cytometry with acri-
dine orange dyeing. The fluorescence emission of green
(510~530 nm) and red (650 nm) from 1 × 10
6 cells was
measured with a flow cytometer using CellQuest soft-
ware. Moreover, the cells were exposed to 20 μMT KV I
for 16 h and localization of LC3-II was detected as
described by Herman [22].
Cell morphological changes detected by electron
microscopy
Ultrastructural change was detected using transmission
electron microscopy with the method as described by
Herman [22] and examined with a JEM-1230 transmis-
sion electron microscope (JEOL, Japan).
Measurement of cytoplasmic calcium level
The changes in cytosolic calcium level ([Ca
2+]c)w e r e
measured by using the cell-permeable Ca
2+-sensitive
fluorescent dye Fluo-3 acetoxymethyl ester (Fluo-3 AM).
The cultures were treated for the designated time with
the indicated concentrations of TK VI diluted in PBS
alone or containing 2 mM CaCl2.A f t e rr i n s i n gt w o
times in HEPES-buffered saline, the live cells were
placed in an open chamber (Molecular Probes, Inc.,
Eugene, OR) with 500 ml of HEPES solution and posi-
tioned on the stage of a Zeiss LSM 510 confocal laser
scanning microscope equipped with an Argon laser. The
raw fluorescence intensities (fluo-3) of user-selected
areas were used for data analyses.
RNA interference
For Bak, the sense and antisense strands of siRNA were,
beginning at nucleotide 310, 5’-UGCCUACGAACU-
CUUCACCdTdT-3’ (sense) and 5’-GGUGAAGA-
GUUCU AGGCAdTdT-3’ (antisense). For Bax, the
sense and antisense strands of siRNA were, beginning at
nucleotide 217, 5’-UAUGGAGCUGCAGAG-
GAUGdTdT-3’ (sense) and 5’-CAUCCUCUGCAGC
UCCAUAdTdT-3’ (antisense). Non-specific control
siRNA (target 5’-GCATTGTATGCGATCGCAGAC-3’)
was served as a control. The transfection of siRNA oli-
gonucleotides was performed with Lipofectamine 2000
(Invitrogen) according to the manufacturer’s recommen-
dations. After 48 h, the cells were treated with TK VI
for the indicated times. At the end of treatment, cells
were harvested for experiments.
Western blot
Proteins in mitochondrial and cytosolic fractions were
extracted using cytochrome c releasing apoptosis detec-
tion kit (Biovision, Mountain View, CA). Protein con-
centration was determined using a BCA protein assay
kit (Bioteke). Equal amount of proteins (20 μg) was
loaded onto SDS-PAGE gels and the proteins were elec-
trically transferred to a PVDF film (Amersham, Ayes-
bury, UK). Immunoblots were analyzed using specific
primary antibodies against Bcl-xl, calpain, Bax, Bak,
LC3, caspase-3, PARP, Smac, Cyc-c and b-actin, and
proteins were visualized using an advanced chemilumi-
nescence detection kit (Amersham, Ayesbury, UK). b-
actin was used for internal control to confirm that the
amount of protein was equal.
Immunohistochemical studies
HepG2 cells (5 × 10
4) were seeded in 12-well plates.
After being washed with PBS, cells were incubated with
100 nM MitoTracker for 30 min and fixed with ice-cold
4% paraformaldehyde. The fixed cells were subsequently
incubated with the primary antibody rabbit anti-Bak and
Smac (1:500) or mouse anti-Bax and cytochrome c
(1:200) in blocking solution (1.5% bovine serum albumin
in TBST) for 1 h at room temperature, and then stained
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respectively. Cells were examined under a Zeiss LSM
510 confocal laser scanning microscope. Data was repre-
sentative of at least three independent experiments.
Statistical analysis
All results were expressed as mean ± SD. P < 0.05 was
considered statistically significant. All statistical analyses
were performed using SPSS 11.5 for Windows.
Additional file 1: Identification of strain SMF2. Strain SMF2 grew on
PDA (potato dextrose agar) medium plate at 28°C in darkness and its
morphological character was observed. The 18S rDNA and ITS (internal
transcribed spacer) sequences of strain SMF2 were amplified from its
genomic DNA by PCR. The sequence of 18S rDNA and ITS gene were,
respectively, blasted in GenBank database. Strain SMF2 was named as T.
pseudokoningii SMF2 based on its colony and conidiophore morphology
as well as its 18S rDNA and ITS sequences.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-4598-9-26-
S1.DOC]
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